Project Details
Project
Galderma Group AG - Corporate ESG Assesment
Client
Galderma Group AG
Project Type
Corporate ESG Assessment
Industry Group
Pharmaceuticals
Use of Proceeds
N/A
Location
Switzerland
Evaluation Date
Feb 2024
Evaluation Summary
Galderma Group AG has been provided with an indicative Corporate ESG Assessment by Sustainalytics, a Morningstar company and a globally recognized provider of ESG research, ratings, and data, which provides research-based on its independent methodology, and publicly available information from issuers.
The Corporate ESG Assessment provided for Galderma Group AG, and enclosed herein, is a one-off point in time assessment, valid at the time of its delivery and follows the same research framework and methodology as for Sustainalytics ESG Risk Rating, however, this shall not be read nor construed as an ESG Risk Rating.
https://mstar-sustops-cdn-mainwebsite-s3.s3.amazonaws.com/docs/default-source/spos/galderma_group_ag_corporateesgassessment_03_08_2024.pdf?sfvrsn=2ce1f252_1